Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2002 | |
| Gross Profit | N/A | N/A | N/A | N/A | 2,940 |
| Operating Expenses | 28,706 | 6,814 | 4,343 | 4,446 | 1,750 |
| Operating Income | -28,706 | -6,814 | -4,343 | -4,446 | -1,750 |
| Interest Expense | 0 | 2,052 | 3,449 | 1,808 | 0 |
| Other Income | -48 | -17 | 0 | 0 | 0 |
| Pre-tax Income | -28,754 | -8,883 | -7,792 | -6,255 | -1,750 |
| Net Income Continuous | -28,754 | -8,883 | -7,792 | -6,255 | -1,750 |
| Net Income | $-28,754 | $-8,883 | $-7,792 | $-6,255 | $-1,750 |
| EPS Basic Total Ops | -0.98 | -1.28 | -1.46 | -1.28 | N/A |
| EPS Basic Continuous Ops | -0.98 | -1.28 | -1.44 | -1.25 | N/A |
| EPS Diluted Total Ops | -0.98 | -1.28 | -1.46 | -1.28 | N/A |
| EPS Diluted Continuous Ops | -0.98 | -1.28 | -1.44 | -1.25 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.98 | -0.88 | N/A | N/A | N/A |
| EBITDA(a) | $-27,305 | $-5,385 | $-1,692 | $-3,294 | $-1,040 |